Pharma

Researchers Secure £3.9M Grant to Explore Early Axonal Dysfunction in ALS and FTD

Collaborative project involving researchers from King’s College London and University College London looks to develop therapeutic strategies for amyotrophic lateral sclerosis and frontotemporal dementia.

NHS Introduces Groundbreaking Gene Therapy for Beta Thalassaemia

In a landmark advancement for genetic medicine, the NHS is set to offer a revolutionary gene therapy, Casgevy, to patients with transfusion-dependent beta thalassaemia.

Basel, Switzerland - Feburary 07, 2023: The twin tower of the Roche Tower

Roche Accelerates Anti-Obesity Drug Development to Rival Eli Lilly and Novo Nordisk

Strategic move boosts the Swiss pharmaceutical company's shares.

Biovac Advances Africa's Vaccine Production with Sanofi and EuBiologics Partnerships

In a significant move to bolster local vaccine production across Africa, South African pharmaceutical company Biovac has entered into strategic agreements with Sanofi and EuBiologics.

NICE Approves Vertex’s Modulator Drugs for Cystic Fibrosis: A Landmark Decision for the NHS

The National Institute for Health and Care Excellence (NICE) has granted approval for the life-changing cystic fibrosis modulator drugs—Kaftrio, Symkevi, and Orkambi—to be made available through the NHS in England.

Bayer Pharmaceuticals Shakes Up Leadership Structure

Bayer Pharmaceuticals implements leadership streamlining amid restructuring efforts.